Filing Flows › Caribou Biosciences (CRBU) › Next earnings date
Caribou Biosciences (CRBU) earnings: beat the estimate
Caribou Biosciences (CRBU) reported on Nov 5, 2026 and beat the EPS estimate: −$0.25 against −$0.26 (+4.8%). Revenue was $1.6M for Q3 2026, -27% year over year. Caribou Biosciences (CRBU) reports next on Nov 11, 2026 (estimated), in 3 days, for the quarter ending Dec 31, 2026. Analysts expect EPS of −$0.28 (−$0.34 to −$0.20, 4 estimates) on revenue of $18.4M. It beat the EPS estimate in 100% of the quarters on record; Filing Flows' model gives it a 87% chance of beating next time.
What to watch
Last quarter (Q3 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
The last report
Caribou Biosciences reported revenue of $1.6M for the third quarter 2026 (-27% Y/Y), net loss $26.6M. How it makes money → · Every quarter →
Caribou Biosciences' latest quarter
Caribou Biosciences, Q3 2026: revenue $1.6M (-27% year over year), net loss $26.6M, operating cash flow −$22.5M. The chart follows the revenue to costs, profit and cash.
Questions
Did Caribou Biosciences beat earnings?
Caribou Biosciences (CRBU) reported on Nov 5, 2026 and beat the EPS estimate: −$0.25 against −$0.26 (+4.8%).
When does CRBU report earnings?
Caribou Biosciences is expected to report on Nov 11, 2026 (estimated).
What are analysts expecting from Caribou Biosciences?
EPS of −$0.28 and revenue of $18.4M for the quarter.
Does Caribou Biosciences usually beat earnings?
It beat the consensus EPS estimate in 100% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.